InspireMD NSPR 深 沪
已收盘 12-19 16:00:00 美东时间
1.96
-0.040
-2.00%
华盛通- 最 高2.13
- 今 开1.97
- 成交量 5.04万股
- 最 低 1.74
- 昨 收 2.00
- 总市值 1631.35万
- 52周最高 3.798
- 市盈率 静 --
- 换手率 0.61%
- 52周最低 1.59
- 委 比 74.86%
- 总股本 832.32万
- 历史最高 67987500.00
- 量 比 0.83
- 振 幅 19.50%
- 历史最低 0.806
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
InspireMD宣布其CGuard Prime EPS获得欧盟CE认证，用于预防中风。该系统通过独特设计减少栓塞事件，优化了用户反馈，计划在美国申请FDA认证。
06-13 13:00
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
InspireMD appoints Michael Lawless as CFO, replacing Craig Shore after nearly 15 years, to lead the company's growth phase, including the U.S. launch of CGuard Prime. Lawless brings extensive healthcare financial leadership experience. As part of the inducement compensation, he will receive restricted stock and stock options vesting over three years.
06-03 20:05
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
Inspire Medical Systems will present at the Truist Securities MedTech Conference on June 17, 2025, at 11:20 a.m. ET. The presentation will be available via live webcast and a replay will be accessible on Inspire’s Investor website for two weeks post-event. Inspire develops minimally invasive solutions for obstructive sleep apnea, offering the FDA, EU MDR, and PDMA-approved Inspire therapy.
06-03 12:00
Piper Sandler Reiterates Overweight on InspireMD, Maintains $4.5 Price Target
Piper Sandler analyst Adam Maeder reiterates InspireMD (NASDAQ:NSPR) with a Overweight and maintains $4.5 price target.
2024-09-17 22:14
